Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bright Minds Biosciences Inc C.DRUG

Alternate Symbol(s):  DRUG

Bright Minds Biosciences Inc. is a biotechnology company. The Company is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy, and pain. It has a portfolio of next generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as treatment resistant epilepsy, treatment resistant depression, post-traumatic stress disorder (PTSD), and pain. Its pipeline includes BMB-101, BMB-202, and BMB-xxx. BMB-101 is for the treatment of Dravet syndrome and other neurological and neuro-psychiatric disorders. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling while avoiding off-target effects.


CSE:DRUG - Post by User

Post by Possibleidiot01on Nov 07, 2024 9:51am
15 Views
Post# 36300834

Mathieu Martin - Stocks and Stones - The Good, The Bad......

Mathieu Martin - Stocks and Stones - The Good, The Bad......
  • I was unsure which category to put this one in. On October 15, the shares of Bright Minds Biosciences (CSE: DRUG) went parabolic on seemingly no news. And when I say parabolic, I mean a 25 times increase (2,500%) in one day. Apparently, one of their peers in the US developing a similar drug was acquired the day before for $2.6 billion, and US hedge funds immediately jumped on Bright Minds. The stock went on a crazy run, reaching a high of $108 per share from only $1.64 a few days prior, a 65-bagger in four days. The company immediately arranged a fully subscribed US $35 million financing, and the CEO unloaded $12 million worth of stock in the market at $40 per share. It's still unclear whether this is legit or another pump & dump. I guess time will tell. In the meantime, this one has been pretty captivating to watch.

<< Previous
Bullboard Posts
Next >>